Trials / Withdrawn
WithdrawnNCT03363022
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure- A Double Blind Controlled Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
All patients of Acute liver failure not meeting the KCH (King's College Hospital) criteria/or meeting KCH criteria not having option of liver transplant will be recruited for the trial. The first group will receive Standard medical care with Fecal Microbiota transplant on Day 1 for 3 consecutive days. FMT (Fecal Microbiota Transplant) will be delivered rectally which will be placed bedside. Suitable donor will be screened and the stool samples will be used as per criteria. Stool samples will be taken at the time at Day 0, 1(Post FMT), Day 4, 6, 14,21. Sepsis screen will be sent. Inflammatory markers will be sent on Day 0,1, 4,6, 14,21. The second group will receive standard medical therapy/and an placebo. Stool samples will be sent on Day 0,1, 4, 6 , 14,21. Inflammatory markers will be sent on the time on day 0,1 4,6 , 14,21.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Standard Medical Treatment | Standard Medical Treatment includes antibiotics,CRRT (Continuous Renal replacement Therapy),Liver Dialysis. |
| OTHER | Fecal Microbiota Transplant | Fecal Microbiota Transplant Stool specimen (preferably Bristol Stool Type 3 or 4) with a weight of ∼50 g will be considered adequate. 250 mL sterile normal saline will be added to the stool sample and homogenized with a blender for 2-4minutes in pulses of 30 seconds with 10 seconds wait in between each pulse. Enema to be held for 30 minutes. |
| OTHER | Placebo | Placebo will be identical and non medicinal to the Fecal Microbiota Transplant |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2017-12-05
- Last updated
- 2019-11-05
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03363022. Inclusion in this directory is not an endorsement.